Delivery Order SPE2DR25D2104-SPE2DR26F4BRA
Award Date 4/28/26
Potential Completion Date 4/29/26
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $21,649.09 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for supply of Everolimus 1 mg tablets (60-count units), with an ultimate completion date of March 9, 2026. The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $12,749.86 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Everolimus 10 mg tablets (30-count units). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 26, 2026....
- <p>The Defense Logistics Agency issued a $17,995.64 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for Everolimus 1 mg tablet UD 60s, with ultimate completion on March 12, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $19,751.88 delivery order to AmerisourceBergen Drug Corp on April 8, 2026, for Everolimus 0.75 mg tablets (60-count units), with an ultimate completion date of April 9, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical commodities globally to support military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $6,979.16 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Everolimus 10 mg tablets (30-count packages), with an ultimate completion date of April 2, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 and running through December 2026. This IDC provides pharmaceutical and medical supply support globally to military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $9,487.88 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for Everolimus 1 mg tablet UD 60s, with a completion date of March 27, 2026. This is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. The order is firm fixed price with no set-aside. Place of...
- The Defense Logistics Agency issued a $12,749.86 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Everolimus 10 mg tablets (30 count). The order is firm fixed price with an ultimate completion date of March 19, 2026 and is performed in Conshohocken, PA. The delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency issued a $26,618.90 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Everolimus 10 mg tablets (30-count). The order is issued under the parent Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC provides global pharmaceutical support to military healthcare programs, covering a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency issued a $22,445.56 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for supply of Everolimus 1 mg tablets (60-count units). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that provides pharmaceutical and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an...
- The Defense Logistics Agency issued a $53,689.47 delivery order to AmerisourceBergen Drug Corp on April 21, 2026, for Everolimus 10 mg tablets (30-count). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX series), which supplies brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to the Department of Defense and federal healthcare systems. Place of performance is Conshohocken, Pennsylvania. The order...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F4BRADelivery Order
The Defense Logistics Agency issued a $13,525.93 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for Everolimus 1 mg tablet (60-count). The order is firm fixed price with no set-aside. Place of performance is Conshohocken, PA. Ultimate completion date is April 29, 2026. The parent vehicle is the DLA Troop Support Medical IDC under which Amerisourcebergen holds a single-award indefinite delivery contract valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 7/27/26, 10:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 4/27/26 |